Describing the Profile of Patients on Concurrent Rifampin and Warfarin Therapy in Western Kenya: A Case Series

BACKGROUND: Rifampicin’s ability to induce hepatic enzymes is responsible for causing a clinically significant drug interaction with warfarin. Little data exists to guide clinicians on managing this interaction, especially in Sub-Saharan Africa where many patients are exposed to this combination due...

Descripción completa

Detalles Bibliográficos
Autores principales: Maina, M. W., Pastakia, S. D., Manji, I., Kirui, N., Kirwa, C., Karwa, Rakhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784049/
https://www.ncbi.nlm.nih.gov/pubmed/23982688
http://dx.doi.org/10.1007/s40268-013-0023-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784049/
https://www.ncbi.nlm.nih.gov/pubmed/23982688
http://dx.doi.org/10.1007/s40268-013-0023-7

Ejemplares similares